Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Collagen Biostimulator Injection
Ingredient: Saline suspension consisting of 3.5% pig collagen
Specification: 1 ml
Package: Bottle
Application Area: Eye depression, fine lines, lying silkworm, crow's feet, dark circles, mouth youthful, forehead wrinkles, eyebrow lines, etc.
Product Introduction：
Our collagen filler serves as an effective filler for soft tissue deficiencies. The FDA has approved collagen-based implants for treating wrinkles and restoring volume to depressed areas. Type I Collagen can promotes collagen matrix regeneration, improving skin laxity, sagging, and hollowness for a firmer, more youthful appearance. Type III Collagen can repairs damaged fibrous tissues, helping to smooth rough skin, brighten dullness, and restore lost elasticity for a rejuvenated glow.
Product Display：
Product Details:
Type | Collagen Filler |
Ingredient | Saline suspension consisting of 3.5% pig collagen |
Specification | 1ml |
Effect area | corium |
Application area | Eye depression, fine lines, lying silkworm, crow's feet, dark circles, mouth youthful, forehead wrinkles, eyebrow lines, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Store at 2 ~ 8ºC, do not freeze |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | At least 3 consecutive treatments as a small course, each treatment interval of 2 to 3 months |
Collagen content | 38mg/ml |
Product Package:
Customer Feedback：
Raw Material Advantages：
Skin-Origin Advantage: Composed of 90% Type I and 10% Type III collagen, mirroring the natural collagen distribution in human skin.
Porcine-Origin Advantage: Boasting over 95% amino acid sequence similarity to human collagen, it does not require skin testing, unlike bovine collagen.
Biological Structure & Activity Benefit: Features an intact triple-helix structure with immunogenic elements fully removed. It is a white gel with no Tyndall effect.
Development Process:
Company Introduction:
Capitalizing on 15 years of dedicated experience in polysaccharide modification and crosslinking, our medical-grade material modification platform converts chitosan to carboxymethyl chitosan—reflected in our successful surgical anti-adhesion fluid product—and modifies sodium hyaluronate to crosslinked sodium hyaluronate via sophisticated biphasic, monophasic, and micro-crosslinking methods, while our microsphere fabrication capabilities yield crosslinked starch microspheres (as seen in our composite microporous polysaccharide hemostatic powder) and cutting-edge injectable PCL, PLLA, and PMMA microspheres.
